[1] ZHANG S,JIA J,BI X,et al. Sarcomatoid carcinoma of the common bile duct:A case report[J]. Medicine(Baltimore),2017,96(3):e5751.
|
[2] GANESHAN D,MORON FE,SZKLARUK J. Extrahepatic biliary cancer:New staging classification[J]. World J Radiol,2012,4(8):345-352.
|
[3] ALBRECHT T,MEHRABI A,STROBEL O,et al. Spindle and giant cell type undifferentiated carcinoma of the distal bile duct:A case report[J]. Z Gastroenterol,2019,57(1):52-56.
|
[4] ROSAI J. Carcinoma of pancreas simulating giant cell tumor of bone. Electron-microscopic evidence of its acinar cell origin[J]. Cancer,1968,22(2):333-344.
|
[5] HARATAKE J,YAMADA H,HORIE A,et al. Giant cell tumorlike cholangiocarcinoma associated with systemic cholelithiasis[J]. Cancer,1992,69(10):2444-2448.
|
[6] LIAO X,HOULDSWORTH J,LUO J,et al. Polypoid undifferentiated carcinoma with osteoclast-like giant cells arising in the distal common bile duct:A rare case report[J]. Anticancer Res,2019,39(1):437-441.
|
[7] XU RF,SUN JP,ZHANG SR,et al. KRAS and PIK3CA but not BRAF genes are frequently mutated in Chinese cholangiocarcinoma patients[J]. Biomed Pharmacother,2011,65(1):22-26.
|
[8] GARG M. Epithelial-mesenchymal transition-activating transcription factors-multifunctional regulators in cancer[J]. World J Stem Cells,2013,5(4):188-195.
|
[9] SUNG CO,CHOI H,LEE KW,et al. Sarcomatoid carcinoma represents a complete phenotype with various pathways of epithelial mesenchymal transition[J]. J Clin Pathol,2013,66(7):601-606.
|
[10] KIM HJ,KIM JS,JOO MK,et al. Hepatolithiasis and intrahepatic cholangiocarcinoma:A review[J]. World J Gastroenterol,2015,21(48):13418-13431.
|
[11] XU J,LI JD. Diagnosis and treatment experience of intrahepatic hepatolithiasis associated with cholangiocarcinoma[J/CD]. Chin J Liver Dis:Electronic Edition,2018,7(2):115-118.(in Chinese)徐建,李敬东.肝内胆管结石合并胆管癌诊治经验[J/CD].中华肝脏外科手术学电子杂志,2018,7(2):115-118.
|
[12] WATANABE M,CHIGUSA M,TAKAHASHI H,et al. High level of CA19-9,CA50,and CEA-producible human cholangiocarcinoma cell line changes in the secretion ratios in vitro or in vivo[J]. In Vitro Cell Dev Biol Anim,2000,36(2):104-109.
|
[13] LIU YB,WANG XA. Problems and strategy in surgical treatment of biliary tract tumors[J]. Chin J Dig Surg,2019,18(2):117-122.(in Chinese)刘颖斌,王许安.胆道恶性肿瘤外科治疗的问题和对策[J].中华消化外科杂志,2019,18(2):117-122.
|
[14] NAKAJIMA T,TAJIMA Y,SUGANO I,et al. Intrahepatic cholangiocarcinoma with sarcomatous change. Clinicopathologic and immunohistochemical evaluation of seven cases[J]. Cancer,1993,72(6):1872-1877.
|